Skip to main content

Discriminative and Analgesic Effects of Mu and Kappa Opioids: In Vivo pA2 Analysis

  • Chapter
Transduction Mechanisms of Drug Stimuli

Part of the book series: Psychopharmacology Series ((PSYCHOPHARM,volume 4))

Abstract

This paper illustrates the use of antagonists to study receptor mediation of the discriminative stimulus effects of opioids and to determine if their analgesic effects are mediated in a similar manner. Analysis by pA2 was used to quantify interactions between the opioid antagonist quadazocine and several opioid agonists. Interactions were examined under a drug discrimination procedure and under a tail withdrawal analgesia procedure. Values of pA2 for quadazocine in combination with the kappa agonists bremazocine, ethylketazocine, and U50,488 ranged between 6.1 and 6.4 under the drug discrimination and tail withdrawal procedures. In contrast, the pA2 values for the mu agonists etorphine, fentanyl, and morphine under these procedures ranged between 7.6 and 8.2. The difference between these pA pA2 values indicates that the affinity of quadazocine for the receptors mediating the effects of the kappa agonists is over one log unit lower than its affinity for the receptors mediating the effects of the mu agonists. This suggests that the discriminative stimulus and analgesic effects of kappa opioid agonists are mediated at the same opioid receptor type, which is different from the type of opioid receptor at which mu agonists produce their discriminative stimulus and analgesic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bertalmio AJ, Woods JH (1987) Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis. J Pharmacol Exp Ther 243:591–597

    PubMed  CAS  Google Scholar 

  • Bertalmio AJ, Herling S, Hampton RY, Winger G, Woods JH (1982) A procedure for rapid evaluation of the discriminative stimulus effects of drugs. J Pharmacol Methods 7:289–299

    Article  PubMed  CAS  Google Scholar 

  • Bertalmio A J, Winger GD, Woods JH (1984) Mu and kappa receptor-mediated opioid discriminative effects in rhesus monkeys: pA analysis. Fed Proc 43:966

    Google Scholar 

  • Casy AF, Parfitt RT (1986) Opioid analgesics: chemistry and receptors. Plenum, New York

    Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1976a) On the ability of narcotic antagonists to produce the narcotic cue. J Pharmacol Exp Ther 197:180–187

    PubMed  CAS  Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1976b) The narcotic discriminative stimulus complex: relation to analgesic activity. J Pharm Pharmacol 28:183–187

    Article  PubMed  CAS  Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1978a) Narcotic cueing and analgesic activity of narcotic analgesics: associative and dissociative characteristics. Psychopharmacology 57:21–26

    Article  PubMed  CAS  Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ, Van Ree JM (1978b) Narcotic cueing properties of intraventricularly administered sufentanil, fentanyl, morphine and met-enkephalin. Eur J Pharmacol 47:115–119

    Article  PubMed  CAS  Google Scholar 

  • Dykstra LA (1983) Development of enhanced sensitivity to naloxone. Life Sci 33:2079–2089

    Article  PubMed  CAS  Google Scholar 

  • Dykstra LA (1985) Behavioral and pharmacological factors in opioid analgesia. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Liss, New York, pp 111–129

    Google Scholar 

  • Dykstra LA, Woods JH (1986) A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. J Pharmacol Methods 15:263–269

    Article  PubMed  CAS  Google Scholar 

  • Dykstra LA, Gmerek DE, Winger G, Woods JH (1987a) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413–420

    PubMed  CAS  Google Scholar 

  • Dykstra LA, Gmerek DE, Winger G, Woods JH (1987b) Kappa opioid agonists in rhesus monkeys. II. Analysis of the antagonist actions of quadazocine and ß-funaltrexamine. J Pharmacol Exp Ther 242:421–127

    PubMed  CAS  Google Scholar 

  • Gmerek DE, Dykstra LA, Woods JH (1987) Kappa opioids in rhesus monkeys: III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428–436

    PubMed  CAS  Google Scholar 

  • Hayashi G, Takemori AE (1971) The type of analgesic-receptor interaction involved in certain analgesic assays. Eur J Pharmacol 16:63–66

    Article  PubMed  CAS  Google Scholar 

  • Hayes A, Kelly A (1985) Profile of activity of k receptor agonists in the rabbit vas deferens. Eur J Pharmacol 110:317–322

    Article  PubMed  CAS  Google Scholar 

  • Hein DW, Young AM, Herling S, Woods JH (1981) Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey. J Pharmacol Exp Ther 218:7–15

    PubMed  CAS  Google Scholar 

  • Herling S, Shannon HE (1982) Discriminative effects of ethylketazocine in the rat: stereospeciflcity and antagonism by naloxone. Life sci 31:2371–2374

    Article  PubMed  CAS  Google Scholar 

  • Herling S, Woods JH (1981a) Discriminative stimulus effects of etorphine in rhesus monkeys. Psychopharmacology 72:265–267

    Article  PubMed  CAS  Google Scholar 

  • Herling S, Woods JH (1981b) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life sci 28:1571–1584

    Article  PubMed  CAS  Google Scholar 

  • Holtzman SG (1985) Discriminative stimulus properties of opioids that interact with mu, kappa, and PCP/sigma receptors. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Liss, New York, pp 131–147

    Google Scholar 

  • James IF, Goldstein A (1984) Site-directed alkylation of multiple opioid receptors 1. Binding selectivity. Mol Pharmacol 25:337–342

    Google Scholar 

  • Kosterlitz HW, Waterfield AA, Berthoud V (1974) Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum. In: Braude MC, Harris LS, May EL, Smith JP, Villarreal JE (eds) Advances in biochemical psychopharmacology, vol 8. Raven, New York, pp 319–334

    Google Scholar 

  • Krimmer EC, Barry H III (1982) Measuring naloxone antagonism of discriminative opioid stimulus. Fed Proc 41:2319–2322

    PubMed  CAS  Google Scholar 

  • Lahti RA, Von Voigtlander PF, Barsuhn C (1982) Properties of a selective kappa agonist, U- 50,488H. Life sci 31:2257–2260

    Article  PubMed  CAS  Google Scholar 

  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532

    PubMed  CAS  Google Scholar 

  • McGilliard KL, Takemori AE (1978) Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J Pharmacol Exp Ther 207:494–503

    PubMed  CAS  Google Scholar 

  • Michne WF, Lewis TR, Michalec SJ, Pierson AK, Gillan MGC, Paterson SJ, Robson LE, Kosterlitz HW (1978) Novel developments of -methylbenzomorphan narcotic antagonists. In: van Ree JM, Terenius L (eds) Characteristics and function of opioids. Elsevier, Amsterdam, pp 197–206

    Google Scholar 

  • Porreca F, Cowan A, Raffa RB, Tallarida RJ (1982) On the criteria for classifying opiate agonists in rats. J Pharm Pharmacol 34:525–526

    Article  PubMed  CAS  Google Scholar 

  • Richards ML, Sadee W (1985) In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: Comparison with urine output in the rat. J Pharmacol Exp Ther 233:425–432

    PubMed  CAS  Google Scholar 

  • Römer D, Büscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK, Akkerman AM (1980) Bremazocine: a potent, long-acting opiate kappa-agonist. Life sci 27:971–978

    Article  PubMed  Google Scholar 

  • Schild HO (1947) Drug antagonism. Br J Pharmacol Chemother 2:189–206

    PubMed  CAS  Google Scholar 

  • Sehmauss C, Yaksh TL (1984) In vivo studies on spinal opiate receptor systems mediating anti- nociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 228:1–12

    Google Scholar 

  • Shannon HE, Cone EJ, Gorodetzky CW (1984) Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone. J Pharmacol Exp Ther 229:768–774

    PubMed  CAS  Google Scholar 

  • Takemori AE (1974) Determination of pharmacological constants: use of narcotic antagonists to characterize analgesic receptors. In: Braude MC, Harris LS, May EL, Smith JP, Villarreal JE (eds) Advances in biochemical psychopharmacology, vol 8. Raven, New York, pp 335–344

    Google Scholar 

  • Takemori AE, Kupferberg HJ, Miller JW (1969) Quantitative studies of the antagonism of morphine by nalorphine and naloxone. J Pharmacol Exp Ther 169:39–45

    PubMed  CAS  Google Scholar 

  • Takemori AE, Hayashi G, Smits SE (1972) Studies on the quantitative antagonism of analgesics by naloxone and diprenorphine. Eur J Pharmacol 20:85–92

    Article  PubMed  CAS  Google Scholar 

  • Tallarida RJ, Harakal C, Maslow J, Geller EB, Adler MW (1978) The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine. J Pharmacol Exp Ther 206:38–45

    PubMed  CAS  Google Scholar 

  • Teal J J, Holtzman SG (1980) Stimulus effects of morphine in the monkey: quantitative analysis of antagonism. Pharmacol Biochem Behav 12:587–593

    Article  PubMed  CAS  Google Scholar 

  • Von Voigtlander PF, Lewis RA (1982) U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Prog Neuro-Psychopharmacol Biol Psychiatry 6:467–470

    Article  Google Scholar 

  • Von Voigtlander PF, Lahti RA, Ludens JH (1983) U-50,488: a selective and structurally novel non-raw (kappa) opioid agonist. J Pharmacol Exp Ther 224:7–12

    Google Scholar 

  • Ward SJ, Takemori AE (1983) Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J Pharmacol Exp Ther 224:525–530

    PubMed  CAS  Google Scholar 

  • Ward SJ, Pierson AK, Michne WF (1983) Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist WIN 44,441–3. Life Sci 33, Sup 1:303–306

    Google Scholar 

  • Wood PL, Pilapil C, Thakur M, Richard JW (1984) WIN 44,441: a stereospecific and long-acting narcotic antagonist. Pharm Res 1:46–48

    Article  Google Scholar 

  • Yaksh TL, Rudy TA (1977) A dose ratio comparison of the interaction between morphine and cyclazocine with naloxone in rhesus monkeys on the shock titration task. Eur J Pharmacol 46:83–92

    Article  PubMed  CAS  Google Scholar 

  • Young AM, Woods JH (1982) Limitations on the antagonistic actions of opioid antagonists. Fed Proc 41:2333–2338

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dykstra, L.A., Bertalmio, A.J., Woods, J.H. (1988). Discriminative and Analgesic Effects of Mu and Kappa Opioids: In Vivo pA2 Analysis. In: Colpaert, F.C., Balster, R.L. (eds) Transduction Mechanisms of Drug Stimuli. Psychopharmacology Series, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73223-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73223-2_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73225-6

  • Online ISBN: 978-3-642-73223-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics